- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03784612
The Healthy Eating With APP technologY Study (HAPPY)
October 3, 2023 updated by: Stephanie Bonn, Karolinska Institutet
The HAPPY-study: Digital Support for Healthier Eating Habits in Patients With Diabetes Type 2 - a Randomized Clinical Trial Within Primary Care
The aim of this study is to investigate the effect of using new app-based technology to improve dietary habits, compared to usual care in patients with type 2 diabetes.
The hypothesis is that the intervention, i.e. using the new technology an an app-based course for healthy eating habits, will have a greater positive effect on dietary habits and biological markers, including HbA1c and serum lipids, than usual care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
133
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephanie E Bonn, PhD
- Phone Number: 0046851779173
- Email: stephanie.bonn@ki.se
Study Locations
-
-
-
Stockholm, Sweden
- Karolinska Institutet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Have a diagnosis of type 2 diabetes
- 18 years of age or older
- Ability to communicate in Swedish
- Own and use a smartphone with a personal digital ID
Exclusion criteria:
- No specific exclusion criteria apply
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: App-technology group
Participants in the App-technology group arm will use a newly developed smartphone application ("app"), containing a 12-week healthy eating program. Intervention: App-technology for healthy eating habits. |
Access to smartphone-app, including a 12 week healthy eating program.
A new theme on healthy dietary habits is presented each week.
|
No Intervention: Control group
The control group will receive standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in dietary intake
Time Frame: Baseline and month 3, and 6
|
Change in dietary intake assessed using a four day food record
|
Baseline and month 3, and 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c
Time Frame: Baseline and month 3, and 6
|
mmol/mol, Heamoglobin A1c
|
Baseline and month 3, and 6
|
Total cholesterol
Time Frame: Baseline and month 3, and 6
|
mmol/L
|
Baseline and month 3, and 6
|
HDL-cholesterol
Time Frame: Baseline and month 3, and 6
|
mmol/L
|
Baseline and month 3, and 6
|
Triglycerides
Time Frame: Baseline and month 3, and 6
|
mmol/L
|
Baseline and month 3, and 6
|
Body Mass Index (BMI)
Time Frame: Baseline and month 3, and 6
|
kg/m2, measured height and weight
|
Baseline and month 3, and 6
|
Body weight
Time Frame: Baseline and month 3, and 6
|
kg, measured
|
Baseline and month 3, and 6
|
Body composition: Body fat
Time Frame: Baseline and month 3, and 6
|
Body fat (kg), measured using a bioelectrical scale
|
Baseline and month 3, and 6
|
Body composition: Fat free mass
Time Frame: Baseline and month 3, and 6
|
Fat free mass (kg), measured using a bioelectrical scale
|
Baseline and month 3, and 6
|
Body composition: Muscle mass
Time Frame: Baseline and month 3, and 6
|
Muscle mass (kg), measured using a bioelectrical scale
|
Baseline and month 3, and 6
|
Body composition: Total body water
Time Frame: Baseline and month 3, and 6
|
Total body water (kg), measured using a bioelectrical scale
|
Baseline and month 3, and 6
|
Waist circumference
Time Frame: Baseline and month 3, and 6
|
cm, measured
|
Baseline and month 3, and 6
|
Blood pressure
Time Frame: Baseline and month 3, and 6
|
mmHg, measured
|
Baseline and month 3, and 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in dietary intake and eating habits
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a 94 item food frequency questionnaire (FFQ)
|
Baseline and month 3, 6 and 12
|
Change in eating behaviour assessed using Three-Factor Eating Questionnaire-R21 (TFEQ-R21)
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a 21-item questionnaire
|
Baseline and month 3, 6 and 12
|
Change in physical activity assessed using the Active-Q questionnaire
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a 48 item questionnaire including activities in domains of Daily occupation, transportation, leisure time, and exercise
|
Baseline and month 3, 6 and 12
|
Change in self-reported medication use
Time Frame: Baseline and month 3, 6 and 12
|
One question on medication use for blood sugar levels and one questions on medication use for blood lipid levels
|
Baseline and month 3, 6 and 12
|
Change in tobacco use habits
Time Frame: Baseline and month 3, 6 and 12
|
Two questions regarding smoking and Swedish snuff use
|
Baseline and month 3, 6 and 12
|
Change in sleeping habits
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a modified 13-item Karolinska Sleep questionnaire
|
Baseline and month 3, 6 and 12
|
Change in perceived purpose in Life (PIL)
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using 6-item questionnaire
|
Baseline and month 3, 6 and 12
|
Change in perceived stress levels
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using the 14-item perceived stress scale (PSS)
|
Baseline and month 3, 6 and 12
|
Change in self-reported diabetes self-efficacy
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a 20-item questionnaire
|
Baseline and month 3, 6 and 12
|
Change in health related quality of life
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using the 36-item RAND-36 questionnaire
|
Baseline and month 3, 6 and 12
|
Change in perceived social support from family and friends for healthy eating habits
Time Frame: Baseline and month 3, 6 and 12
|
Assessed using a 3-item questionnaire
|
Baseline and month 3, 6 and 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephanie E Bonn, PhD, Karolinska Institutet
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2019
Primary Completion (Actual)
August 31, 2023
Study Completion (Actual)
August 31, 2023
Study Registration Dates
First Submitted
December 14, 2018
First Submitted That Met QC Criteria
December 21, 2018
First Posted (Actual)
December 24, 2018
Study Record Updates
Last Update Posted (Actual)
October 4, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dnr: 2018/652-31
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on App-technology for healthy eating habits
-
Nicole OosteromRecruitingType 2 Diabetes | Lifestyle | Prehabilitation | Vascular SurgeryNetherlands
-
Chang Gung University of Science and TechnologyChang Gung Memorial Hospital; Ministry of Science and Technology, TaiwanRecruiting
-
University of CincinnatiRecruiting
-
Queen's University, BelfastUniversity College, London; University of Leeds; Belfast Health and Social Care... and other collaboratorsCompletedPregnancy Related | Overweight and ObesityUnited Kingdom
-
Florida State UniversityCompleted
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR); Roswell Park Cancer InstituteCompleted
-
State University of New York at BuffaloNational Institute of Nursing Research (NINR)Completed
-
University of PittsburghMassachusetts General HospitalCompletedAutism Spectrum DisorderUnited States
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Stanford UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | InsomniaUnited States